Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Independence Blue Cross	Pulse Oximetry Device in the Home SettingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-042	New policy
Aug 2, 2026	Independence Blue Cross	Pulmonary RehabilitationPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA10-001	New policy
Aug 2, 2026	Independence Blue Cross	Psychological TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA14-002	New policy
Aug 2, 2026	Independence Blue Cross	Psychiatric Collaborative Care Management (CoCM)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-052	New policy
Aug 2, 2026	Independence Blue Cross	Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-036	New policy
Aug 2, 2026	Independence Blue Cross	Prophylactic Mastectomy, Oophorectomy/Salpingo-Oophorectomy, and HysterectomyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-077	New policy
Aug 2, 2026	Independence Blue Cross	Programmed Death Receptor-1 (PD-1) Antagonists (e.g., Keytruda, Opdivo) and Programmed Death-Ligand 1 (PD-L1) Antagonists (e.g., Tecentriq, Bavencio, Imfinzi)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-010	New policy
Aug 2, 2026	Independence Blue Cross	Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-055	New policy
Aug 2, 2026	Independence Blue Cross	Procedures for the Treatment of AcnePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-109	New policy
Aug 2, 2026	Independence Blue Cross	Private Duty NursingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA02-002	New policy
Aug 2, 2026	Independence Blue Cross	Preventive Care ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-003AH-2B334B660F	New policy
Aug 2, 2026	Independence Blue Cross	Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management TreatmentsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-025	New policy
Aug 2, 2026	Independence Blue Cross	Pressure-Reducing Support SurfacesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-025	New policy
Aug 2, 2026	Independence Blue Cross	Prescription Digital Therapeutics and Mobile-Based Health Management ApplicationsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA12-011	New policy
Aug 2, 2026	Independence Blue Cross	PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-010AV-527C0CC5C1	New policy
Aug 2, 2026	Independence Blue Cross	PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-010AV-CBEA5340F8	New policy
Aug 2, 2026	Independence Blue Cross	Pozelimab-bbfg (Veopoz)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-167	New policy
Aug 2, 2026	Independence Blue Cross	Power Wheelchairs (PWCs), Power-Operated Vehicles (POVs), and Power-Assist System DevicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-032	New policy
Aug 2, 2026	Independence Blue Cross	Positron Emission Mammography (PEM)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA09-015	New policy
Aug 2, 2026	Independence Blue Cross	Polatuzumab vedotin-piiq (Polivy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-108	New policy
Aug 2, 2026	Independence Blue Cross	Pneumatic Compression Therapy DevicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-004	New policy
Aug 2, 2026	Independence Blue Cross	Photodynamic Therapy Using Verteporfin (Visudyne)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-003	New policy
Aug 2, 2026	Independence Blue Cross	Photodynamic Therapy (PDT) Using Porfimer Sodium (Photofrin)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-030	New policy
Aug 2, 2026	Independence Blue Cross	Photodynamic Therapy (PDT) Using Levulan Kerastick or Ameluz (Aminolevulinic Acid HCl [ALA])PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-056	New policy
Aug 2, 2026	Independence Blue Cross	Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-014	New policy
Aug 2, 2026	Independence Blue Cross	Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-129	New policy
Aug 2, 2026	Independence Blue Cross	Pertuzumab (Perjeta) and related biosimilar pertuzumab-dpzb  (Poherdy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-063	New policy
Aug 2, 2026	Independence Blue Cross	Personalized Vaccines (e.g., Provenge)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-053	New policy
Aug 2, 2026	Independence Blue Cross	Peroral Endoscopic Myotomy (POEM) ProceduresPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-117	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass SurgeryPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-056	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation (NVAF)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-013	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Intradiscal Annuloplasty (IDET/PIRFT)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-025	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Image-Guided Lumbar Decompression (PILD) for Spinal StenosisPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-097	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-064	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous DiscectomyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-096	New policy
Aug 2, 2026	Independence Blue Cross	Percutaneous Coronary Intervention, Coronary Angiography, and Arterial UltrasoundPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-113	New policy
Aug 2, 2026	Independence Blue Cross	Penpulimab-kcqxPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-186	New policy
Aug 2, 2026	Independence Blue Cross	Pemetrexed (Pemfexy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-047	New policy
Aug 2, 2026	Independence Blue Cross	Pembrolizumab and berahyaluronidase alfa-pmph (KEYTRUDA QLEX)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-189	New policy
Aug 2, 2026	Independence Blue Cross	Pembrolizumab (Keytruda)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-121	New policy
Aug 2, 2026	Independence Blue Cross	Pegloticase (Krystexxa)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-060	New policy
Aug 2, 2026	Independence Blue Cross	patisiran (Onpattro) and vutrisiran (Amvuttra)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-100	New policy
Aug 2, 2026	Independence Blue Cross	Patient LiftsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-031	New policy
Aug 2, 2026	Independence Blue Cross	Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant SkinPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-073	New policy
Aug 2, 2026	Independence Blue Cross	Pain Management of Peripheral Nerves by InjectionPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-047	New policy
Aug 2, 2026	Independence Blue Cross	Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-049	New policy
Aug 2, 2026	Independence Blue Cross	Outpatient Physical Medicine and Rehabilitation Services- Physical Therapy (PT) and Occupational Therapy (OT)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA10-003	New policy
Aug 2, 2026	Independence Blue Cross	Otoplasty or Non-Surgical External Ear MoldingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-058	New policy
Aug 2, 2026	Independence Blue Cross	Ostomy SuppliesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-014	New policy
Aug 2, 2026	Independence Blue Cross	Orthopedic FootwearPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-012	New policy